1. Home
  2. AISP vs GOSS Comparison

AISP vs GOSS Comparison

Compare AISP & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

HOLD

Current Price

$2.52

Market Cap

77.7M

Sector

Finance

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.33

Market Cap

88.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AISP
GOSS
Founded
2006
2015
Country
United States
United States
Employees
63
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.7M
88.6M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
AISP
GOSS
Price
$2.52
$0.33
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$4.19
AVG Volume (30 Days)
467.9K
5.5M
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$48,471,000.00
Revenue This Year
$222.88
N/A
Revenue Next Year
$5.36
$201.64
P/E Ratio
$3.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$0.32
52 Week High
$7.20
$3.87

Technical Indicators

Market Signals
Indicator
AISP
GOSS
Relative Strength Index (RSI) 54.73 33.48
Support Level $2.07 N/A
Resistance Level $2.82 $0.47
Average True Range (ATR) 0.15 0.03
MACD 0.02 0.01
Stochastic Oscillator 61.36 4.00

Price Performance

Historical Comparison
AISP
GOSS

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture. Airship AI's software allows customers to view structured data both in real-time as well as to conduct searches on the structured data at a later point in time.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: